563 followers
cohort study: The reduction in HAMD score was 36% less pronounced and response rate was 75% lower in slow metabolizers of CYP2C19 vs. normals. The Toronto Side-Effects Scale intensity score was increased in SMs by 43% for CNS and by 22% for GI AEs https:/